Bio-Rad Laboratories Inc - Class B
Research Bio-Rad Laboratories Inc - Class B (BIO-B) on Bullrun: market cap USD 7.99B, P/E 49.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIO-B
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 7.99B
- P/E49.8
- Financial periodQ1 2026
- RevenueUSD 592.10M
- Net income-USD 527.10M
- Free cash flowUSD 78.10M
- Gross margin52.3%
Valuation Snapshot
latest market cap is USD 7.99B; P/E is 49.8.
Peer valuation comparison
Latest P/E is 49.75x versus a Healthcare sector median of 24.46x (103.4% above).
Latest P/E is 49.75x versus a United States median of 24.87x (100.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.58B | USD 759.90M | USD 374.60M | 51.9% | 27.85 | USD 529.80M | USD 1.20B | USD 7.45B |
| FY2024 | USD 2.57B | -USD 1.84B | USD 289.60M | 53.7% | -65.36 | USD 488.10M | USD 1.20B | USD 6.57B |
| FY2023 | USD 2.67B | -USD 637.30M | USD 218.20M | 53.4% | -21.82 | USD 403.80M | USD 1.20B | USD 8.74B |
| FY2022 | USD 2.80B | -USD 3.63B | USD 81.60M | 55.9% | -121.79 | USD 434.20M | USD 1.20B | USD 9.62B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-07-13 | USD 7.99B | 49.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 USD.
About Bio-Rad Laboratories Inc - Class B
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bio-Rad Laboratories Inc - Class B's market cap?
Bio-Rad Laboratories Inc - Class B's market capitalization is USD 7.99B.
What is Bio-Rad Laboratories Inc - Class B's P/E ratio?
Bio-Rad Laboratories Inc - Class B's price-to-earnings (P/E) ratio is 49.8.
What does Bio-Rad Laboratories Inc - Class B do?
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.